Shares of MAP Pharmaceuticals (MAPP -5.3%) slide today after the company priced its secondary...

|About: MAP Pharmaceuticals, Inc. (MAPP)|By:, SA News Editor

Shares of MAP Pharmaceuticals (MAPP -5.3%) slide today after the company priced its secondary offering of 3.88M shares at $13.40, a 5% discount to yesterday's close. The company intends to use the proceeds to bring its investigational migraine drug Levadex to market, as well as for other general corporate purposes.